Metabolic syndrome surgery
|
Metabolic syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Metabolic syndrome surgery On the Web |
|
American Roentgen Ray Society Images of Metabolic syndrome surgery |
|
Risk calculators and risk factors for Metabolic syndrome surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
Metabolic syndrome occurs in the presence of insulin resistance and accompanying obesity. It increases the risk for coronary heart disease, diabetes, fatty liver, stroke and some cancers. It may manifests as hypertension, hyperglycemia, hypertriglyceridemia, reduced high-density lipoprotein cholesterol and abdominal obesity. It affects a large number of people in a clustered fashion. In some studies, the prevalence in the USA is calculated as being up to 25% of the population.
Surgical therapy is not routinely performed for metabolic syndrome. However, in cases of morbid obesity and unresponsiveness of medical therapy bariatric surgery can be performed. The beneficial effects of surgery is thought to be due to the weight loss after surgery that in turn decreases the insulin resistance. Also, increased secretion of gut hormones such as glucagon-like peptide-1 (GLP-1) accompanies the surgery and thus helps in metabolic syndrome.